Market revenue in 2023 | USD 30.2 million |
Market revenue in 2030 | USD 35.1 million |
Growth rate | 2.2% (CAGR from 2023 to 2030) |
Largest segment | Soil-transmitted helminthiases |
Fastest growing segment | Leishmaniases |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne Trematode Infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African Trypanosomiasis (sleeping sickness), Soil-transmitted Helminthiases, Onchocerciasis, Schistosomiasis, Scabies and Other Ecoparasites, Snakebite Envenoming, Leishmaniases |
Key market players worldwide | Roche, Abbott Laboratories, Thermo Fisher Scientific Inc, Eurobio-Scientific, Omega Laboratories, Avacta Group PLC, Oscar Health Inc Class A, ZeptoMetrix, InBios, DiaSys Diagnostic Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neglected tropical diseases diagnosis market will help companies and investors design strategic landscapes.
Soil-transmitted helminthiases was the largest segment with a revenue share of 9.6% in 2023. Horizon Databook has segmented the Canada neglected tropical diseases diagnosis market based on dengue, chikungunya, rabies, leprosy, buruli ulcer, yaws, lymphatic filariasis, taeniasis/cysticercosis, foodborne trematode infections, echinococcosis, chagas disease, dracunculiasis, human african trypanosomiasis (sleeping sickness), soil-transmitted helminthiases, onchocerciasis, schistosomiasis, scabies and other ecoparasites, snakebite envenoming, leishmaniases covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of NTDs is relatively low in Canada in comparison with other Asian and African countries. According to PLOS Neglected Tropical Diseases, among NTDs, only echinococcosis, rabies, and scabies are considered endemic in Canada.
In addition, increasing immigration is one of the crucial factors responsible for its increased growth rate. According to CCIRC, Inc., around 330,800 in 2019, 341,000 in 2020, and 350,000 in 2021 immigrants were recorded in Canada.
Furthermore, drastic weather changes in Canada are expected to positively impact overall market growth. These factors are responsible for its increased market share over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada neglected tropical diseases diagnosis market , including forecasts for subscribers. This country databook contains high-level insights into Canada neglected tropical diseases diagnosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account